HC Deb 25 February 1997 vol 291 cc182-3W
Ms Roseanna Cunningham

To ask the Secretary of State for Health what monitoring for Creutzfeldt-Jacob disease he has undertaken among patients who have received human growth hormone treatment; and if he will make a statement. [17259]

Mr. Horam

The monitoring of patients treated with human growth hormone has, since 1992, been undertaken by the human pituitary growth hormone follow-up unit at the Institute of Child Health, London.

Ms Cunningham

To ask the Secretary of State for Health how many people in England and Wales(a) before 1 July 1977 and (b) after 1 July 1997 have (i) received human growth hormone treatment, (ii) died as a result of human growth hormone treatment, and (iii) been diagnosed as ill as a result of human growth hormone treatment; and how many court actions have been raised, or are currently pending, as a result of death or illness following such treatment. [17260]

Mr. Horam

The available information covers the whole of the United Kingdom.

(i). The number who received human growth hormone treatment
Number
Up to 31 December 1976 641
1 January 1977 to 31 December 1977 138
Since 1 January 1978 1,122

The data are available by calendar year only.

  1. (ii) The number of human hormone patients who have died of Creutzfeldt-Jacob disease: 20
  2. (iii) The number of human growth hormone patients with the symptoms of Creutzfeldt-Jacob disease: two
  3. (iv) Number of court actions: one
  4. (v) Number of court actions pending (including appeals): two

Forward to